Moreover, the suppression of VEGFR2 phosphorylation levels reduces the PI3K/AKT signaling pathway, resulting in alterations in CCA cell proliferation, apoptosis, and invasion [9]. The gene discussed is AKT1; the disease is cholangiocarcinoma.